ロード中...
Ketanserin in essential hypertension: a double-blind, placebo-controlled study.
The antihypertensive effect of the selective serotonin antagonist ketanserin was examined in a double-blind, placebo-controlled, parallel group study in 20 patients with essential hypertension. After 7 weeks treatment with ketanserin (mean dose 71 mg/d) there was a significant fall of both systolic...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Group
1985
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2418322/ https://ncbi.nlm.nih.gov/pubmed/3161013 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|